Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Development of a New Mouse Model for Coxsackievirus-Induced Myocarditis by Attenuating Coxsackievirus B3 Virulence in the Pancreas.

Pinkert S, Pryshliak M, Pappritz K, Knoch K, Hazini A, Dieringer B, Schaar K, Dong F, Hinze L, Lin J, Lassner D, Klopfleisch R, Solimena M, Tschöpe C, Kaya Z, Beling A, Kurreck J, van Linthout S, Klingel K, Fechner H.

Cardiovasc Res. 2019 Oct 9. pii: cvz259. doi: 10.1093/cvr/cvz259. [Epub ahead of print]

PMID:
31598635
2.

Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction.

Friebel J, Weithauser A, Witkowski M, Rauch BH, Savvatis K, Dörner A, Tabaraie T, Kasner M, Moos V, Bösel D, Gotthardt M, Radke MH, Wegner M, Bobbert P, Lassner D, Tschöpe C, Schutheiss HP, Felix SB, Landmesser U, Rauch U.

Eur Heart J. 2019 Oct 21;40(40):3318-3332. doi: 10.1093/eurheartj/ehz117.

PMID:
31004144
3.

Telbivudine Reduces Parvovirus B19-Induced Apoptosis in Circulating Angiogenic Cells.

Zobel T, Bock CT, Kühl U, Rohde M, Lassner D, Schultheiss HP, Schmidt-Lucke C.

Viruses. 2019 Mar 6;11(3). pii: E227. doi: 10.3390/v11030227.

4.

High-resolution respirometry in human endomyocardial biopsies shows reduced ventricular oxidative capacity related to heart failure.

Scheiber D, Jelenik T, Zweck E, Horn P, Schultheiss HP, Lassner D, Boeken U, Saeed D, Kelm M, Roden M, Westenfeld R, Szendroedi J.

Exp Mol Med. 2019 Feb 14;51(2):16. doi: 10.1038/s12276-019-0214-6.

5.

Disconnect between Fibrotic Response and Right Ventricular Dysfunction.

Crnkovic S, Egemnazarov B, Damico R, Marsh LM, Nagy BM, Douschan P, Atsina K, Kolb TM, Mathai SC, Hooper JE, Ghanim B, Klepetko W, Fruhwald F, Lassner D, Olschewski A, Olschewski H, Hassoun PM, Kwapiszewska G.

Am J Respir Crit Care Med. 2019 Jun 15;199(12):1550-1560. doi: 10.1164/rccm.201809-1737OC.

PMID:
30557518
6.

CCR5del32 genotype in human enteroviral cardiomyopathy leads to spontaneous virus clearance and improved outcome compared to wildtype CCR5.

Lassner D, Siegismund CS, Kühl U, Rohde M, Stroux A, Escher F, Schultheiss HP.

J Transl Med. 2018 Sep 4;16(1):249. doi: 10.1186/s12967-018-1610-8.

7.

Telbivudine in chronic lymphocytic myocarditis and human parvovirus B19 transcriptional activity.

Van Linthout S, Elsanhoury A, Klein O, Sosnowski M, Miteva K, Lassner D, Abou-El-Enein M, Pieske B, Kühl U, Tschöpe C.

ESC Heart Fail. 2018 Oct;5(5):818-829. doi: 10.1002/ehf2.12341. Epub 2018 Aug 11.

8.

Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.

Müller I, Vogl T, Pappritz K, Miteva K, Savvatis K, Rohde D, Most P, Lassner D, Pieske B, Kühl U, Van Linthout S, Tschöpe C.

Circ Heart Fail. 2017 Nov;10(11). pii: e004125. doi: 10.1161/CIRCHEARTFAILURE.117.004125.

PMID:
29158436
9.

The forkhead transcription factor Foxo3 negatively regulates natural killer cell function and viral clearance in myocarditis.

Loebel M, Holzhauser L, Hartwig JA, Shukla PC, Savvatis K, Jenke A, Gast M, Escher F, Becker SC, Bauer S, Stroux A, Beling A, Kespohl M, Pinkert S, Fechner H, Kuehl U, Lassner D, Poller W, Schultheiss HP, Zeller T, Blankenberg S, Papageorgiou AP, Heymans S, Landmesser U, Scheibenbogen C, Skurk C.

Eur Heart J. 2018 Mar 7;39(10):876-887. doi: 10.1093/eurheartj/ehx624.

PMID:
29136142
10.

Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis.

Siegismund CS, Escher F, Lassner D, Kühl U, Gross U, Fruhwald F, Wenzel P, Münzel T, Frey N, Linke RP, Schultheiss HP.

Eur J Heart Fail. 2018 Apr;20(4):751-757. doi: 10.1002/ejhf.1039. Epub 2017 Oct 25.

11.

Human Parvovirus B19 (B19V) Up-regulates CXCR4 Surface Expression of Circulating Angiogenic Cells: Implications for Cardiac Ischemia in B19V Cardiomyopathy.

Schmidt-Lucke C, Zobel T, Escher F, Tschöpe C, Lassner D, Kühl U, Gubbe K, Volk HD, Schultheiss HP.

J Infect Dis. 2018 Jan 17;217(3):456-465. doi: 10.1093/infdis/jix309.

PMID:
28961998
12.

NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.

Tschöpe C, Müller I, Xia Y, Savvatis K, Pappritz K, Pinkert S, Lassner D, Heimesaat MM, Spillmann F, Miteva K, Bereswill S, Schultheiss HP, Fechner H, Pieske B, Kühl U, Van Linthout S.

Circ Heart Fail. 2017 Sep;10(9). pii: e003870. doi: 10.1161/CIRCHEARTFAILURE.117.003870.

PMID:
28912259
13.

High Perforin-Positive Cardiac Cell Infiltration and Male Sex Predict Adverse Long-Term Mortality in Patients With Inflammatory Cardiomyopathy.

Escher F, Kühl U, Lassner D, Stroux A, Gross U, Westermann D, Pieske B, Poller W, Schultheiss HP.

J Am Heart Assoc. 2017 Aug 18;6(8). pii: e005352. doi: 10.1161/JAHA.116.005352.

14.

Immunosuppressive treatment in fulminant myocarditis and gene expression pattern associated with, but no histological confirmation of giant cell myocarditis.

Fruhwald F, Lassner D, Fruhwald S, Gross UM, Dapunt O, Schultheiss HP.

ESC Heart Fail. 2017 May;4(2):190-192. doi: 10.1002/ehf2.12130. Epub 2017 Jan 31.

15.

High Prevalence of Infectious Adeno-associated Virus (AAV) in Human Peripheral Blood Mononuclear Cells Indicative of T Lymphocytes as Sites of AAV Persistence.

Hüser D, Khalid D, Lutter T, Hammer EM, Weger S, Heßler M, Kalus U, Tauchmann Y, Hensel-Wiegel K, Lassner D, Heilbronn R.

J Virol. 2017 Jan 31;91(4). pii: e02137-16. doi: 10.1128/JVI.02137-16. Print 2017 Feb 15.

16.

Mitochondrial haplogroups and expression studies of commonly used human cell lines.

Siegismund CS, Schäfer I, Seibel P, Kühl U, Schultheiss HP, Lassner D.

Mitochondrion. 2016 Sep;30:236-47. doi: 10.1016/j.mito.2016.08.012. Epub 2016 Aug 22.

PMID:
27562426
17.

Absent MicroRNAs in Different Tissues of Patients with Acquired Cardiomyopathy.

Siegismund CS, Rohde M, Kühl U, Escher F, Schultheiss HP, Lassner D.

Genomics Proteomics Bioinformatics. 2016 Aug;14(4):224-34. doi: 10.1016/j.gpb.2016.04.005. Epub 2016 Jul 28.

18.

Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy.

Escher F, Kühl U, Lassner D, Poller W, Westermann D, Pieske B, Tschöpe C, Schultheiss HP.

Clin Res Cardiol. 2016 Dec;105(12):1011-1020. Epub 2016 Jun 16.

PMID:
27312326
19.

Long noncoding RNA MALAT1-derived mascRNA is involved in cardiovascular innate immunity.

Gast M, Schroen B, Voigt A, Haas J, Kuehl U, Lassner D, Skurk C, Escher F, Wang X, Kratzer A, Michalik K, Papageorgiou A, Peters T, Loebel M, Wilk S, Althof N, Prasanth KV, Katus H, Meder B, Nakagawa S, Scheibenbogen C, Schultheiss HP, Landmesser U, Dimmeler S, Heymans S, Poller W.

J Mol Cell Biol. 2016 Apr;8(2):178-81. doi: 10.1093/jmcb/mjw003. Epub 2016 Jan 27. No abstract available.

20.

Supplemental Content

Loading ...
Support Center